Extendicare (TSE:EXE – Get Free Report) had its target price boosted by analysts at TD from C$32.00 to C$39.00 in a research report issued on Monday,BayStreet.CA reports. The brokerage presently has a “buy” rating on the stock. TD’s target price would suggest a potential upside of 22.18% from the company’s previous close.
Other equities research analysts also recently issued reports about the company. BMO Capital Markets lifted their target price on Extendicare from C$24.00 to C$30.00 in a report on Monday, March 2nd. Canadian Imperial Bank of Commerce lifted their target price on Extendicare from C$22.00 to C$32.00 in a report on Thursday, April 2nd. TD Securities upgraded Extendicare from a “hold” rating to a “buy” rating and lifted their target price for the stock from C$19.00 to C$32.00 in a report on Monday, April 6th. National Bank Financial lifted their target price on Extendicare from C$24.50 to C$29.00 and gave the stock an “outperform” rating in a report on Thursday, February 5th. Finally, Desjardins set a C$34.50 target price on Extendicare and gave the stock a “buy” rating in a report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating and six have given a Buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of C$30.44.
View Our Latest Stock Analysis on Extendicare
Extendicare Trading Down 4.5%
Extendicare (TSE:EXE – Get Free Report) last issued its earnings results on Thursday, May 7th. The company reported C$0.42 earnings per share for the quarter. The business had revenue of C$465.22 million during the quarter. Extendicare had a return on equity of 45.35% and a net margin of 6.99%. On average, equities research analysts predict that Extendicare will post 0.6134729 EPS for the current year.
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Featured Stories
- Five stocks we like better than Extendicare
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
